Express Scripts, FTC
PBM strikes back at FTC over drug pricing report
The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of the report, which the company claims is "unfair, biased, erroneous, and defamatory" against the PBM industry and is "seventy-four pages of unsupported innuendo."
Express Scripts sues FTC over report scrutinizing PBM practices
As the FTC has increasingly prodded PBMs over their role in high drug costs, Express Scripts is fighting back by launching a lawsuit against the agency.
Express Scripts sues FTC over 'flawed and biased' PBM report
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the pharmacy provided to investigators.
Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory and asking the court to order the FTC to withdraw the report.
Cigna's Express Scripts sues FTC over 'defamatory' PBM report
Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade Commission and its chair, Lina Khan, over what the company asserts was a report filled with false and misleading claims about how pharmacy benefit management firms operate.
Express Scripts files suit against FTC, demands retraction of report on PBM industry
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry. | Express Scripts has filed suit against the Federal Trade Commission,
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
Cigna's Express Scripts Sues FTC, Demands Withdrawal Of PBM Report; Stock Down
Express Scripts by Evernorth, a unit of Cigna Group (CI), Tuesday said it has filed a lawsuit against the Federal Trade Commission or
Express Scripts sues FTC, demands withdrawal of PBM report
In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) Express Scripts demanded that the Federal Trade Commission (FTC) retract its July 2024 report,
Express Scripts Sues FTC Over PBM Report
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry.
Express Scripts sues FTC and demands drug pricing report retraction
The US-based pharmacy benefit manager (PBM) claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.
Fierce Healthcare23h
FTC formally sues PBMs over insulin prices and warns manufacturers
Express Scripts files suit against FTC, demands retraction of report on PBM industry These PBMs value high rebates from ...
Morningstar4d
Cigna's PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
alleging that the agency's July report on the PBM industry was biased and defamatory and asking the court to order the FTC to withdraw the report. The report is "seventy-four pages of unsupported ...
The American Journal of Managed Care17h
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Fortune15h
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
Lawmakers from both parties have sharply questioned PBM practices and called for new laws to force more transparency, ...
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits ...